1
Home
Companies

Taiko Pharmaceutical

Taiko Pharmaceutical
Leadership team

Mr. Takashi Shibata (Pres, CEO & Representative Director)

Tsuyoshi Honma (Exec. Officer of Accounting & IT)

Konosuke Tanaka (Exec. Officer of Personnel Affairs & PR)

Products/ Services
Health Care, Medical, Pharmaceutical
Number of Employees
100 - 500
Headquarters
Osaka, Osaka, Japan
Established
1946
Revenue
20M - 100M
Traded as
TYO:4574
URL
https://www.seirogan.co.jp
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`
History

Taiko Pharmaceuticals was established in 1945 with the goal of developing innovative pharmaceuticals to improve the health of the world. Over the years, we have built a world-class portfolio of drugs and treatments that address some of the world’s toughest health problems.

Mission
Our mission is to contribute to the improved health, longevity and quality of life of people everywhere by developing and delivering innovative biopharmaceuticals.
Vision
Our vision is to become the most trusted and respected biopharmaceutical company in the world, providing life-changing therapies and health solutions to patients, families and health care providers around the world.
Key Team

Takatoshi Osada (Sr. Exec. Officer of Marketing & Sales)

Mitsuhiro Yamashita (Exec. Officer of Overseas Bus.)

Shinichi Seki (Exec. Officer & GM of Infection Control Bus. Devel. Division)

Keizo Nakada (Exec. Officer)

Recognition and Awards
Taiko Pharmaceuticals has been recognised for our commitment to innovation and excellence. We have been recognised by the Japan Pharmacists Association as the top-rated biopharmaceutical firm in Japan, as well as honoured with numerous awards from leading industry organisations.
References

https://in.investing.com/equities/taiko-pharmaceutical

https://finance.yahoo.com/quote/4574.T/profile?p=4574.T

https://www.crunchbase.com/organization/taiko-pharmaceutical

https://companiesmarketcap.com/

https://www.seirogan.co.jp

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Taiko Pharmaceutical
Leadership team

Mr. Takashi Shibata (Pres, CEO & Representative Director)

Tsuyoshi Honma (Exec. Officer of Accounting & IT)

Konosuke Tanaka (Exec. Officer of Personnel Affairs & PR)

Products/ Services
Health Care, Medical, Pharmaceutical
Number of Employees
100 - 500
Headquarters
Osaka, Osaka, Japan
Established
1946
Revenue
20M - 100M
Traded as
TYO:4574
URL
https://www.seirogan.co.jp